AVDL Annual Total Liabilities
$76.96 M
-$76.97 M-50.00%
31 December 2023
Summary:
As of January 20, 2025, AVDL annual total liabilities is $76.96 million, with the most recent change of -$76.97 million (-50.00%) on December 31, 2023. During the last 3 years, it has fallen by -$72.41 million (-48.48%). AVDL annual total liabilities is now -62.17% below its all-time high of $203.41 million, reached on December 31, 2016.AVDL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Quarterly Total Liabilities
$83.59 M
-$3.64 M-4.18%
30 September 2024
Summary:
As of January 20, 2025, AVDL quarterly total liabilities is $83.59 million, with the most recent change of -$3.64 million (-4.18%) on September 30, 2024. Over the past year, it has increased by +$6.63 million (+8.62%). AVDL quarterly total liabilities is now -68.43% below its all-time high of $264.81 million, reached on March 31, 2018.AVDL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.0% | +8.6% |
| 3 y3 years | -48.5% | +44.7% |
| 5 y5 years | -59.0% | +44.7% |
AVDL Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | at low | -53.3% | +44.7% |
| 5 y | 5-year | -57.4% | at low | -53.7% | +44.7% |
| alltime | all time | -62.2% | +1214.9% | -68.4% | +1328.2% |
Avadel Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $83.59 M(-4.2%) |
| June 2024 | - | $87.23 M(-2.5%) |
| Mar 2024 | - | $89.52 M(+16.3%) |
| Dec 2023 | $76.96 M(-50.0%) | $76.96 M(-17.2%) |
| Sept 2023 | - | $92.95 M(+60.9%) |
| June 2023 | - | $57.78 M(-67.7%) |
| Mar 2023 | - | $178.91 M(+16.2%) |
| Dec 2022 | $153.93 M(-8.9%) | $153.93 M(-2.7%) |
| Sept 2022 | - | $158.20 M(-1.9%) |
| June 2022 | - | $161.27 M(-2.8%) |
| Mar 2022 | - | $165.90 M(-1.8%) |
| Dec 2021 | $169.02 M(+13.2%) | $169.02 M(+2.4%) |
| Sept 2021 | - | $165.13 M(+0.9%) |
| June 2021 | - | $163.71 M(+4.6%) |
| Mar 2021 | - | $156.44 M(+4.7%) |
| Dec 2020 | $149.37 M(-17.3%) | $149.37 M(-4.5%) |
| Sept 2020 | - | $156.44 M(-1.8%) |
| June 2020 | - | $159.28 M(-9.3%) |
| Mar 2020 | - | $175.66 M(-2.8%) |
| Dec 2019 | $180.63 M(-3.7%) | $180.63 M(-1.2%) |
| Sept 2019 | - | $182.85 M(-0.3%) |
| June 2019 | - | $183.49 M(+0.2%) |
| Mar 2019 | - | $183.20 M(-2.3%) |
| Dec 2018 | $187.52 M(+11.8%) | $187.52 M(-7.7%) |
| Sept 2018 | - | $203.26 M(-6.2%) |
| June 2018 | - | $216.69 M(-18.2%) |
| Mar 2018 | - | $264.81 M(+57.9%) |
| Dec 2017 | $167.70 M(-17.6%) | $167.70 M(-7.3%) |
| Sept 2017 | - | $180.96 M(-0.8%) |
| June 2017 | - | $182.43 M(-8.6%) |
| Mar 2017 | - | $199.61 M(-1.9%) |
| Dec 2016 | $203.41 M(+39.4%) | $203.41 M(-3.7%) |
| Sept 2016 | - | $211.15 M(+6.7%) |
| June 2016 | - | $197.87 M(+6.8%) |
| Mar 2016 | - | $185.31 M(+27.0%) |
| Dec 2015 | $145.95 M(-2.3%) | $145.95 M(-15.6%) |
| June 2015 | - | $172.91 M(+5.3%) |
| Mar 2015 | - | $164.16 M(+9.9%) |
| Dec 2014 | $149.31 M(+18.7%) | $149.31 M(+20.1%) |
| Sept 2014 | - | $124.34 M(+6.5%) |
| June 2014 | - | $116.77 M(+12.7%) |
| Mar 2014 | - | $103.61 M(-17.6%) |
| Dec 2013 | $125.76 M(+44.9%) | $125.76 M(-4.7%) |
| Sept 2013 | - | $131.92 M(+2.7%) |
| June 2013 | - | $128.47 M(+27.1%) |
| Mar 2013 | - | $101.05 M(+16.4%) |
| Dec 2012 | $86.81 M | $86.81 M(-19.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $108.35 M(+2.8%) |
| Mar 2012 | - | $105.43 M(+166.2%) |
| Dec 2011 | $39.61 M(+3.4%) | $39.61 M(-1.8%) |
| Sept 2011 | - | $40.33 M(-8.8%) |
| June 2011 | - | $44.22 M(+23.0%) |
| Mar 2011 | - | $35.96 M(-6.1%) |
| Dec 2010 | $38.31 M(-22.5%) | $38.31 M(-12.8%) |
| Sept 2010 | - | $43.92 M(+15.2%) |
| June 2010 | - | $38.12 M(-10.0%) |
| Mar 2010 | - | $42.34 M(-14.3%) |
| Dec 2009 | $49.43 M(+14.1%) | $49.43 M(+3.3%) |
| Sept 2009 | - | $47.85 M(+10.5%) |
| June 2009 | - | $43.30 M(+3.0%) |
| Mar 2009 | - | $42.04 M(-3.0%) |
| Dec 2008 | $43.31 M(-7.4%) | $43.31 M(+13.7%) |
| Sept 2008 | - | $38.10 M(-13.9%) |
| June 2008 | - | $44.23 M(-7.6%) |
| Mar 2008 | - | $47.87 M(+2.3%) |
| Dec 2007 | $46.77 M(+11.7%) | $46.77 M(-3.5%) |
| Sept 2007 | - | $48.48 M(+2.2%) |
| June 2007 | - | $47.45 M(+17.3%) |
| Mar 2007 | - | $40.44 M(-3.4%) |
| Dec 2006 | $41.87 M(+11.1%) | $41.87 M(+6.4%) |
| Sept 2006 | - | $39.34 M(+14.8%) |
| June 2006 | - | $34.27 M(+1.5%) |
| Mar 2006 | - | $33.78 M(-10.4%) |
| Dec 2005 | $37.70 M(+30.7%) | $37.70 M(+12.7%) |
| Sept 2005 | - | $33.45 M(-10.8%) |
| June 2005 | - | $37.48 M(+29.2%) |
| Mar 2005 | - | $29.00 M(+0.5%) |
| Dec 2004 | $28.85 M(-18.0%) | $28.85 M(-8.3%) |
| Sept 2004 | - | $31.46 M(0.0%) |
| June 2004 | - | $31.46 M(-6.3%) |
| Mar 2004 | - | $33.58 M(-4.6%) |
| Dec 2003 | $35.19 M(+226.1%) | $35.19 M(+180.6%) |
| Sept 2003 | - | $12.54 M(-5.1%) |
| June 2003 | - | $13.21 M(+5.6%) |
| Mar 2003 | - | $12.51 M(+15.9%) |
| Dec 2002 | $10.79 M(+1.5%) | $10.79 M(+11.1%) |
| Sept 2002 | - | $9.72 M(-8.6%) |
| Dec 2001 | $10.63 M(+12.2%) | $10.63 M(+12.2%) |
| Dec 2000 | $9.48 M(+61.9%) | $9.48 M(+61.9%) |
| Dec 1999 | $5.85 M(-22.3%) | $5.85 M(-22.3%) |
| Dec 1998 | $7.53 M(+4.6%) | $7.53 M(+0.4%) |
| Mar 1998 | - | $7.50 M(+4.2%) |
| Dec 1997 | $7.20 M(+5.9%) | $7.20 M(+5.9%) |
| Dec 1996 | $6.80 M | $6.80 M(+9.7%) |
| Mar 1996 | - | $6.20 M |
FAQ
- What is Avadel Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual total liabilities year-on-year change?
- What is Avadel Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly total liabilities year-on-year change?
What is Avadel Pharmaceuticals annual total liabilities?
The current annual total liabilities of AVDL is $76.96 M
What is the all time high annual total liabilities for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual total liabilities is $203.41 M
What is Avadel Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, AVDL annual total liabilities has changed by -$76.97 M (-50.00%)
What is Avadel Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of AVDL is $83.59 M
What is the all time high quarterly total liabilities for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly total liabilities is $264.81 M
What is Avadel Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, AVDL quarterly total liabilities has changed by +$6.63 M (+8.62%)